As an endogenous regulator of endothelial cell activation, EGFL7 promotes tumor progression by reducing the expression of endothelial molecules that mediate immune cell infiltration and participate in tumor immune escape mechanisms (Delfortrie et al., 2011). The gene discussed is EGFL7; the disease is neoplasm.